StimOxyGen Revenue and Competitors
Estimated Revenue & Valuation
- StimOxyGen's estimated annual revenue is currently $153k per year.
- StimOxyGen's estimated revenue per employee is $51,000
Employee Data
- StimOxyGen has 3 Employees.
- StimOxyGen grew their employee count by 50% last year.
StimOxyGen's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO, Co-Founder | Reveal Email/Phone |
StimOxyGen Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $27.4M | 244 | 1% | N/A | N/A |
#2 | $2961.7M | 19204 | 6% | N/A | N/A |
#3 | $8.4M | 82 | -15% | N/A | N/A |
#4 | $7.9M | 77 | 1% | N/A | N/A |
#5 | $6.5M | 66 | 22% | N/A | N/A |
#6 | $233.9M | 1638 | N/A | N/A | N/A |
#7 | $8.7M | 85 | N/A | N/A | N/A |
#8 | $133.1M | 932 | 6% | N/A | N/A |
#9 | $9.7M | 95 | -9% | N/A | N/A |
#10 | $6.3M | 69 | 30% | N/A | N/A |
What Is StimOxyGen?
StimOxyGen is a proprietary and world-leading innovative approach to address the global challenge of tumour hypoxia. \n\nHypoxia, or lack of oxygen, is a common characteristic of solid tumours that contributes to the failure of many types of cancer treatment, particularly radiotherapy which relies on oxygen for maximum efficacy. \n\nWe can solve this longstanding major unmet clinical need by fueling tumours with oxygen to maximise therapeutic effects of radiotherapy.
keywords:N/A
N/A
Total Funding
3
Number of Employees
$153k
Revenue (est)
50%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Coleraine
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.6M | 18 | N/A | N/A |
#2 | $2.9M | 23 | 10% | N/A |
#3 | $15.7M | 131 | 4% | N/A |
#4 | $28.7M | 205 | 6% | N/A |
#5 | $111.4M | 330 | 7% | N/A |